From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. STDs>
  4. Archives

STDs: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 1-25 of 508 are shown

Can HPV Vaccination Combat Genital Warts?

Yes — and the benefit extends beyond vaccinated women to their male sexual partners.

Therapeutic HPV Vaccination for Preventing Progression of Vulvar Intraepithelial Neoplasia

Clinical responses were achieved in women with grade 3 VIN who were vaccinated against HPV-16 viral oncoproteins.

Darunavir + Raltegravir + Etravirine = High Rate of Treatment Success

Ninety percent of highly treatment-experienced patients who received this combination achieved virologic suppression at week 24; results were sustained at week 48.

Life Expectancy for HIV-Infected Patients in the U.S.

Average life expectancy continues to improve, but disparities persist.

A Glimmer of Hope for HIV Vaccines

A large trial has shown that a vaccine can protect against HIV acquisition. The task now is to figure out how to build on this initial success.

Ethnicity Affects Attitudes About HPV Vaccination

Ethnic minority women in the U.K. were less likely than white women to know about HPV and to view vaccination as acceptable.

STI and HIV Services Fall Short for Sexually Active Young Women

More than one third of young women who receive contraceptive services are not concurrently offered STI or HIV services.

First HIV Integrase Inhibitor Performs Well in Previously Untreated Patients

Raltegravir and efavirenz yielded similar rates of virologic suppression, but raltegravir had fewer side effects.

HIV Vaccine Study Shows Promise

A new vaccine regimen, tested among more than 16,000 young adults, was found to offer modest protection against HIV acquisition.

Testing for and Prevalence of HCV Infection in HIV-Infected Patients

During a 12-year observational study among HIV-infected patients, the prevalence of HCV coinfection decreased from 37% to 20%.

Primary Care for HIV-Positive Patients

All the usual benchmarks apply to care of HIV-positive patients.

New Hope for HIV Vaccine Development

Using a novel technique, researchers identified antibodies that neutralize a broad array of HIV strains.

For Cervical Cancer, Age Matters — Both the Woman's and Her HPV Infection's

Persistent HPV infection with carcinogenic HPV genotypes was associated with higher risk for CIN 2+; cytology screening was most beneficial in women 35 or older.

Rapid Urine Chlamydia Test for Males Is Highly Sensitive

When tested on first-void urine samples, a new rapid chlamydia test had a sensitivity of 82%.

ART and the Risk for Sexual HIV Transmission

In this study, no transmissions occurred in HIV-infected patients with viral loads <400 copies/mL on ART. However, evidence is still insufficient to estimate the risk of transmission directly or to provide guidance on the use of ART for preventing HIV transmission.

STD Screening Among MSM

During a 2-year period, STD testing was performed at 23% of all MSM visits to a Boston clinic. At least one STD was diagnosed at 11% of those visits.

Quadrivalent HPV Vaccine: Postlicensure Safety Data and Marketing Controversies

Causal nature of qHPV vaccination in relation to adverse events remains unclear; marketing has been criticized for focusing on cervical cancer prevention.

A Biomarker for HIV-Associated Cognitive Disorder

A small study demonstrates the usefulness of the peripheral blood monocyte HIV DNA reservoir as a marker for HIV-associated cognitive impairment and a predictor of persistent cognitive dysfunction after adequate control of HIV.

Nonmelanoma Skin Cancers in Patients with HIV Mirror Cancer in the General Population

In persons with HIV infection, as in the general population, the factors most associated with the development of cutaneous malignancies are the traditional ones.

Condoms Prevent Herpes Simplex Virus Type 2!

Consistent users had a significantly reduced risk for genital herpes infection compared with never users.

Novel Approach to Immunization Protects Monkeys from AIDS

Injecting actual antibody genes instead of SIV antigens protected against later SIV infection.

Non–AIDS-Defining Cancer Is More Common in HIV-Infected Than in HIV-Uninfected Men

In the U.S. VA Healthcare System, the incidence of non–AIDS-defining malignancies was 60% higher in HIV-infected patients than in matched HIV-uninfected patients.

Identifying Patients with Acute HIV Infection and Their Partners

In North Carolina, a protocol for negative or indeterminate HIV-antibody results that involved nucleic acid amplification testing, confirmatory antibody testing, and follow-up interviews led to identification of newly infected partners of newly infected patients.

Impressive Results with Raltegravir in Treatment-Naive HIV Patients

Rates of virologic suppression were similar between raltegravir and efavirenz, but drug-related adverse events were less common with raltegravir.

ART Initiation in Resource-Poor Settings

A computer model suggests that starting ART at CD4 counts <350 cells/mm3, rather than <250 cells/mm3, would improve morbidity and mortality and be cost-effective.

Items 1-25 of 508 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.